August 13, 2024
News
Inhalable dry powders of a monoclonal antibody against SARS-CoV-2 virus made by thin-film freeze-drying
Inhalation drug delivery continues to evolve and develop for the delivery of novel compounds. In a recent publication,...August 8, 2024
Lovelace and Gilead Discovery of GS-7682
RSV continues to be a focus area within respiratory health with the release of new vaccines and therapeutics. ...May 2, 2024
Philip Kuehl Co-Authors Article in the Journal of Aerosol Medicine and Pulmonary Drug Delivery
Lovelace Biomedical has an over 70-year history in the area of respiratory drug delivery. Throughout this history, the...December 21, 2023
Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium
Pandemic uncertainties cloud nebulizer use. But the COPD Foundation’s CNC offers science-backed guidance to minimize aerosol risks in...December 19, 2023
Evolving with the FDA Modernization Act
The appropriate utilization of animals within non-clinical research is always on the minds of drug developers. Lovelace Biomedical...October 9, 2023
2023 Willi Stahlhofen awarded to Lovelace Biomedical’s Scientist Conor Ruzycki as a co-author
The Willi Stahlhofen Award is given to a high impact manuscript in the Journal of Aerosol Medicine and...September 21, 2023
Inhalation delivery of nucleic acid gene therapies in preclinical drug development
Inhaled gene therapies hold great promise in treating a number of diseases including cystic fibrosis and certain cancers...June 14, 2023
Lovelace Biomedical Wins 10M to Combat Opioid Overdose
Lovelace Biomedical has recently received 3 new grants and contracts worth over 10 million granted by the National...June 1, 2023
Novel bioanalytical approaches to drug development – 5-AZA a case study to be presented at the 67th ASMS Conference in Atlanta
Within drug development, the quantitation of drug levels within the systemic circulation and target tissues can provide insight...February 17, 2023
Promising Toxicokinetics for Treating Pulmonary Nontuberculous Mycobacteria Infection
Melanie Doyle-Eisele, Ph.D. and Director of Life Sciences, and Philip Kuehl, Ph.D, and Director of Scientific Core Laboratories,...September 16, 2022
Characterization of Dry Powder Inhaler Performance
Dr. Conor Ruzycki, an Aerosol Engineer here at Lovelace Biomedical, has recently published his article titled: Characterization of...April 22, 2022
Lovelace Biomedical will be Presenting Data on the Non-clinical and Clinical Development Work for HFA-152a at the Upcoming RDD Meeting
Lovelace Biomedical is excited to be presenting data on the non-clinical and clinical development work for HFA-152a at...August 1, 2021
Hammad Irshad – Using a Degree in Engineering to Make a Difference in Public Health
Hammad has 18 years experience, and focuses on our aerosol development and delivery for novel therapies. Hammad, tell me what...July 4, 2021
PCR Development, it’s Uses, and Important Research at Lovelace Biomedical, with Bryan Gullick, PhD, Bioanalytical Research Scientist
Staff Spotlight: Bryan Gullick, PhD, Research Scientist Bryan Gullick, PhD, Bioanalytical Research Scientist Bryan, tell us about PCR in the...June 1, 2021
Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route
Follow these critical steps on your path to IND application. By Philip J. Kuehl, PhD, Senior Scientist and Director...January 12, 2021
2020: The Year of the Scientist
2020 was the year of the scientist. In a culture where we primarily celebrate the accomplishments of artists...January 1, 2021
Lovelace Biomedical Staff Spotlight: Tracylyn Yellowhair – Intra-tracheal (IT) Atomization of IT Liquid Delivery of a Test Article
As translational researchers we’re faced with many challenges in determining the best routes and methods for delivering inhaled...December 31, 2020
From our Blog: Expert Pre-Clinical Toxicology – There is No Standard Template!
2019’s ACT meeting in Phoenix, AZ was the 40th Annual Meeting and brought some key highlights to the...October 12, 2020
Are You Getting The Most out of Your Scientific Meeting Attendance?
Thinking about Scientific and professional development. As I reflect upon 2019 and the different trade shows I attended over 2019,...December 12, 2019
Lovelace Biomedical Staff Spotlight: Janet Benson, Senior Scientist
Today’s staff spotlight belongs to Janet Benson. Janet is one of Lovelace’s longest tenured scientist, with decades of...September 12, 2019
Post Meeting Thoughts from the North American Cystic Fibrosis Conference (NACFC)
It was reinvigorating to get out from behind the desk, and out of the lab this past weekend...August 12, 2019
Traumatic Brain Injury – Collaborative Translational Science at Lovelace Biomedical and the Mind Research Network
Traumatic Brain Injury (TBI) is just one of the many areas of scientific study Lovelace Biomedical, along with...August 1, 2019
Lovelace Biomedical Staff Spotlight: Adam Werts – Veterinary Research Scientist
Today, we put the spotlight on Adam Werts. Adam recently joined Lovelace Biomedical as part of our veterinary...July 14, 2019
Updating My Business Plan for Competitive Landscape in the CRO Industry – What a Task!
– Jacob McDonald, CSO – Lovelace Biomedical Last summer, I wrote a business plan for Lovelace Biomedical. It...June 27, 2019
“Beyond Standing Room Only” – Thoughts on the 22nd Annual Meeting of the Society of Gene and Cell Therapy – Dr. Janet Benson
As someone who has watched the ASGCT conference grow fairly steadily over the last 11 years, the growth in...June 1, 2019
RT-PCR Validations: Square Peg/Round Hole?
Jacob McDonald, CSO – Lovelace Biomedical I set a disclaimer right away, in that I have been called...May 30, 2019
Lovelace’s Director of Bioanalytical Operations, Larry Mallis to be on hand to present poster at ASMS 2019 annual conference
Novel bioanalytical approaches to drug development – 5-AZA a case study to be presented at the 67th ASMS Conference...April 29, 2019
Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month
May is Cystic Fibrosis (CF) month. Lovelace has been working in respiratory research for over 70 years, and...April 26, 2019
BIOCHEMISTRY
Biochemistry or biological chemistry is a branch of biology and chemistry involving intense study of different chemical processes...April 25, 2019
BIOINFORMATICS
Bioinformatics involves in-depth understanding of biological data through strategic development of appropriate software tools. This is an interdisciplinary...April 24, 2019
CELL BIOLOGY
Cell biology is the intense study of structure, composition, physiology and functioning of cells which is the most...April 23, 2019
DRUG DESIGN
Preclinical Drug Design or Rational Drug Design is the process of discovering medications. The process of drug design is...April 22, 2019
MOLECULAR BIOLOGY
Molecular Biology is a branch of biology that understands and analysis the molecular structure, composition and functioning of...April 19, 2019
PHARMACEUTICS
Pharmaceutics is one of the divisions of pharmacy. It involves dealing with New Chemical Entities or drugs that...April 18, 2019
SCIENTIFIC RESEARCH
Scientific research is the sequential process of data collection, interpretation, analysis and reporting done in order to make...April 17, 2019
PRECLINICAL RESEARCH
Preclinical research also known as preclinical study or preclinical development is the phase of research conducted prior to...April 16, 2019
TOXICOLOGY
Preclinical Toxicology Research – Toxicology is the process of analyzing and understanding the effects of toxic chemical substances when...April 15, 2019
BIOTECHNOLOGY
Biotechnology is an extensive part of biology involving the development of technically advanced tools and techniques for use...April 10, 2019
Q & A with Audrey Yarbrough, Lovelace’s Senior Quality Assurance Specialist
Audrey will be attending and presenting at the 35th Annual Society of Quality Assurance Conference in Atlanta, GA...March 27, 2019
The FDA’s Guidance for Industry on Bioanalytical Method Validation, and us.
My thoughts, post WRIB annual conference – Larry Mallis, Director of Bioanalytical Operations At the recent WRIB meeting,...March 20, 2019
Who Are You Anyways?
Just a short while back I was in my final stretch of a marathon 31 meetings at the...March 13, 2019
Not bigger, just better…
Holy cow, it is embarrassing to think that when I was a kid we had that slogan printed...March 6, 2019
Is There a Place for “Mom & Pop” Toxicology Laboratories?
I always thought that a Mom-and-Pop designation best fit a small bakery or perhaps a hardware store. Sort...March 5, 2019
Gene Therapy Saved Me – Lovelace Biomedical’s CSO recalls what gene therapy research has done not only for the company, but for himself as well
Gene Therapy Saved Me. I mean, not literally…but certainly from a figurative standpoint. In 2016 I took on...February 1, 2019
THE PATH TO NEW GENE THERAPY: 7 Steps to IND
An increasing number of pharmaceutical and biotech companies are seeking expert help to navigate investigational gene therapies through preclinical...January 31, 2019
Putting the Science First – Dr. Jacob McDonald
Our CSO, Dr. Jacob McDonald discusses the evolving CRO market, emerging trends in preclinical research and how Lovelace...January 10, 2019
Q & A With Dr. Meghan Vermillion, DVM – Who will be speaking at the 2019 ASM Biothreats Conference about Infectious Diseases
Catch Lovelace’s Dr. Meghan Vermillion speaking at the 2019 ASM Biothreats annual conference, which is happening January 29-31. We...January 4, 2019
Lovelace Expands Veterinary Expertise with New Hires
Top veterinary talent is at the core of preclinical success. And the more complex the study, the more...January 1, 2019
A Culture of Continuous Improvement: The Lovelace Approach to Quality
The best-run preclinical research programs are just as devoted to strong science and achieving experimental objectives as they...December 13, 2018
Focus on Infectious Disease: Reducing the Threat of ‘Flu-Imposter’ Adenovirus
It may feel like the flu — and be just as grave of a health threat — but...December 13, 2018
Lovelace Discovers Novel Approach to Overcome Limitations of Nucleoside Assays
Nucleoside analogues are an essential component of many chemotherapies, anti-bacterial drugs and anti-viral agents. These compounds can play...April 1, 2018
Lovelace’s Novel Nucleoside LCMS Assay to Be Presented at 12th Workshop on Regulations in Bioanalysis
Increasingly, biopharmaceutical companies are developing nucleoside analogues as chemotherapeutic, anti-bacterial and anti-viral agents. Of the nucleoside analogues in...March 31, 2018
The Tox Factor: 4 Tips for Drug Sponsors Seeking a Toxicology Partner
Toxicology is often called the “science of safety,” and for good reason. The field is essential in moving...March 22, 2018
Existing Molecules Find New Calling as Medical Countermeasures
Innovation is percolating around new approaches to treating injuries that result from chemical, biological, radiological and nuclear defense,...March 13, 2018
Old Drug, New Tricks: Lovelace Paves Fresh Path for Approved Cancer Therapy
The established cancer drug topotecan may hold promise as a more targeted therapy for patients with small-cell lung...October 9, 2017
Animal Behavioral Management Is Core to Preclinical Success
For preclinical pharmacology and toxicology studies to succeed, it’s essential that investigators and their teams use best practices...October 3, 2017
The Less Cough, the Better: Lovelace Biomedical, Novartis Research Collaboration Aims to Improve Inhaled Drugs
Inhaled medicines play an essential role in treating respiratory conditions and many other diseases, from pulmonary fibrosis to...September 28, 2017
Lovelace Research Spotlight: Aerosol-Delivered Gene Therapy for Cystic Fibrosis
In a key study published in Human Gene Therapy Clinical Development, Lovelace Biomedical researchers found that delivering AAV gene...September 21, 2017
Nose-Only Inhalation of microRNA Shows Promise for Pulmonary Fibrosis
Lovelace Biomedical designed a nose-only inhalation exposure system to evaluate an investigational microRNA-based therapy for pulmonary fibrosis —...September 14, 2017
Overcoming Preclinical Hurdles in Rare Disease Research
For pharmaceutical and biotech companies, rare diseases present huge market opportunities — but also, potentially daunting development challenges....September 7, 2017
qPCR: The Weapon of Choice for Gene and Cell Therapy Biodistribution
To advance a gene or cell therapy product into clinical trials, drug developers must first gain a thorough...August 31, 2017
Lovelace Radiation Research in the Spotlight at National Convention
Lovelace Biomedical’s scientific team will share two recent examples of their advanced preclinical work in defining animal models...August 24, 2017
The Tools and Talent to Investigate the Flu: A Unique CRO Capability
It was nearly a century ago, in 1918, that an influenza pandemic swept the world, killing as many...August 17, 2017
FEATURED WEBINAR: Innovation in Aerosol Drug Formulations
Get an inside look into a 15-year collaboration between the scientists at Lovelace Biomedical and engineers at Capsugel,...August 10, 2017
Breathe Easy: Meeting the Preclinical Challenges of Pulmonary Fibrosis
The race is on for better therapies to treat pulmonary fibrosis, a chronic lung disease characterized by irreversible...August 3, 2017
Lovelace Biomedical Featured in The Scientist: Why Pharma Should Consider Canine Models for Alzheimer’s
The Scientist magazine recently featured an opinion article from Lovelace Biomedical Senior Scientist Edward Barrett, Ph.D., who shared his...March 8, 2017
Lovelace Biomedical’s Advances in Toxicological Research to be Featured at the 56th Annual Meeting of the Society of Toxicology
Albuquerque, N.M., March 8, 2017 – Lovelace Biomedical, a not-for-profit preclinical contract research organization, today announced its participation in...February 1, 2017
A Rich History, An Exciting Future
As you prepare to launch ambitious new projects in 2017, I’d like to personally encourage you to explore...January 25, 2017
Lovelace Biomedical to showcase expertise in inhalation drug delivery as hosts of the International Society of Aerosols in Medicine Congress
The Lovelace Respiratory Research Institute, including the commercially-focused CRO arm Lovelace Biomedical, has been a leader in inhalation...January 18, 2017
Lovelace Biomedical Welcomes Larry Mallis, Ph.D. as Director of Bioanalytical Operations and Further Expands Bioanalytical Chemistry Capabilities
Lovelace Biomedical welcomes Dr. Larry Mallis as Director of Bioanalytical Operations and a key member of the scientific...December 17, 2015
Addressing the Preclinical Development Challenges of Gene Therapy
While the concept of gene therapy has been around for decades, gene therapy companies are just beginning to...December 3, 2015
European Style Housing of Nonhuman Primates
In the United States, laboratory animal research requirements are defined by a combination of the Animal Welfare Act...October 13, 2015